Targeting PI4KA sensitizes refractory leukemia to chemotherapy by modulating the ERK/AMPK/OXPHOS axis.
Autor: | Xiuxing Jiang, Xiangtao Huang, Guoxun Zheng, Guanfei Jia, Zhiqiang Li, Xin Ding, Ling Lei, Liang Yuan, Shuangnian Xu, Ning Gao |
---|---|
Zdroj: | Theranostics; 2022, Vol. 12 Issue 16, p6972-6988, 17p |
Databáze: | Complementary Index |
Externí odkaz: |